QuidelOrtho Corporation
QDEL · NASDAQ
9/28/2025 | 6/29/2025 | 3/30/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 13.8% | -11.2% | -2.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 93.2% | 37.1% | 49.6% | 46.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Income | -$1 | -$0 | $0 | -$0 |
| % Margin | -100.7% | -0.1% | 4.7% | -14.2% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$0 | -$0 | -$0 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$1 | -$0 | -$0 | -$0 |
| % Margin | -104.7% | -41.5% | -1.8% | -25.2% |
| EPS | -10.78 | -3.77 | -0.19 | -2.28 |
| % Growth | -185.9% | -1,884.2% | 91.7% | – |
| EPS Diluted | -10.78 | -3.77 | -0.19 | -2.28 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$0 | $0 | $0 |
| % Margin | -85.5% | -11.9% | 20.3% | 1.9% |